Minerva Neurosciences, Inc. Interest Payable, Current
Minerva Neurosciences, Inc. (NERV) had Interest Payable, Current of $5.22 thousand as of 2018-06-30, per its 10-Q filed 2018-08-02.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2019-03-12
- 2018-06-30: Interest Payable, Current $5.22K.
- 2018-03-31: Interest Payable, Current $12.93K.
- 2017-12-31: Interest Payable, Current $20.51K.
- 2017-09-30: Interest Payable, Current $27.95K.
| Period end | Interest Payable, Current |
|---|---|
| 2018-06-30 | $5.22K 10-Q · filed 2018-08-02 |
| 2018-03-31 | $12.93K 10-Q · filed 2018-05-03 |
| 2017-12-31 | $20.51K 10-K · filed 2019-03-12 |
| 2017-09-30 | $27.95K 10-Q · filed 2017-11-06 |
| 2017-06-30 | $35.27K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $42.46K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $49.52K 10-K · filed 2018-03-12 |
| 2016-09-30 | $56.46K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $58.75K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $58.75K 10-Q · filed 2016-05-03 |
| 2015-12-31 | $58.75K 10-K · filed 2017-03-13 |
| 2015-09-30 | $58.75K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $58.75K 10-Q · filed 2015-08-05 |
| 2015-03-31 | $58.75K 10-Q · filed 2015-05-07 |
| 2014-06-30 | $114.43K 10-Q · filed 2014-08-07 |
| 2013-12-31 | $24.28K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |